|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J. 61:69–90.
2011. View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide: IARC CancerBase No. 11 (Internet). International Agency
for Research on Cancer; Lyon, France: 2013 http://globocan.iarc.frJuly 22–2015
|
|
3
|
Capece D, Fischietti M, Verzella D,
Gaggiano A, Cicciarelli G, Tessitore A, Zazzeroni F and Alesse E
Edoardo: The inflammatory microenvironment in hepatocellular
carcinoma: A pivotal role for tumor-associated macrophages. Biomed
Res Int. 2013:1872042013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cornellà H, Alsinet C and Villanueva A:
Molecular pathogenesis of hepatocellular carcinoma. Alcohol Clin
Exp Res. 35:821–825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS
and Li R: BRCA1-induced large-scale chromatin unfolding and
allele-specific effects of cancer-predisposing mutations. J Cell
Biol. 155:911–921. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Narita T, Yamaguchi Y, Yano K, Sugimoto S,
Chanarat S, Wada T, Kim DK, Hasegawa J, Omori M, Inukai N, et al:
Human transcription elongation factor NELF: Identification of novel
subunits and reconstitution of the functionally active complex. Mol
Cell Biol. 23:1863–1873. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun J and Li R: Human negative elongation
factor activates transcription and regulates alternative
transcription initiation. J Biol Chem. 285:6443–6452. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aiyar SE, Sun JL, Blair AL, Moskaluk CA,
Lu YZ, Ye QN, Yamaguchi Y, Mukherjee A, Ren DM, Handa H, et al:
Attenuation of estrogen receptor α-mediated transcription through
estrogen-stimulated recruitment of a negative elongation factor.
Genes Dev. 18:2134–2146. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Persson I: Estrogens in the causation of
breast, endometrial and ovarian cancers - evidence and hypotheses
from epidemiological findings. J Steroid Biochem Mol Biol.
74:357–364. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Foster JS, Henley DC, Ahamed S and
Wimalasena J: Estrogens and cell-cycle regulation in breast cancer.
Trends Endocrinol Metab. 12:320–327. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun J, Blair AL, Aiyar SE and Li R:
Cofactor of BRCA1 modulates androgen-dependent transcription and
alternative splicing. J Steroid Biochem Mol Biol. 107:131–139.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lonergan PE and Tindall DJ: Androgen
receptor signaling in prostate cancer development and progression.
J Carcinog. 10:202011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma W-L, Lai H-C, Yeh S, Cai X and Chang C:
Androgen receptor roles in hepatocellular carcinoma, fatty liver,
cirrhosis and hepatitis. Endocr Relat Cancer. 21:R165–R182. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aiyar SE, Cho H, Lee J and Li R: Concerted
transcriptional regulation by BRCA1 and COBRA1 in breast cancer
cells. Int J Biol Sci. 3:486–492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aiyar SE, Blair AL, Hopkinson DA,
Bekiranov S and Li R: Regulation of clustered gene expression by
cofactor of BRCA1 (COBRA1) in breast cancer cells. Oncogene.
26:2543–2553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun J, Watkins G, Blair AL, Moskaluk C,
Ghosh S, Jiang WG and Li R: Deregulation of cofactor of BRCA1
expression in breast cancer cells. J Cell Biochem. 103:1798–1807.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McChesney PA, Aiyar SE, Lee OJ, Zaika A,
Moskaluk C, Li R and El-Rifai W: Cofactor of BRCA1: A novel
transcription factor regulator in upper gastrointestinal
adenocarcinomas. Cancer Res. 66:1346–1353. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Midorikawa Y, Tsutsumi S, Taniguchi H,
Ishii M, Kobune Y, Kodama T, Makuuchi M and Aburatani H:
Identification of genes associated with dedifferentiation of
hepatocellular carcinoma with expression profiling analysis. Jpn J
Cancer Res. 93:636–643. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng J-N, Ma T-X, Cao J-Y, Sun X-Q, Chen
J-C, Li W, Wen RM, Sun YF and Pei DS: Knockdown of Ki-67 by small
interfering RNA leads to inhibition of proliferation and induction
of apoptosis in human renal carcinoma cells. Life Sci. 78:724–729.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen WC, Liu Q, Fu JX and Kang SY:
Expression of survivin and its significance in colorectal cancer.
World J Gastroenterol. 10:2886–2889. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang C-CC-C, Park AY and Guan J-LJ-L: In
vitro scratch assay: A convenient and inexpensive method for
analysis of cell migration in vitro. Nat Protoc. 2:329–333. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gebäck T, Schulz MMP, Koumoutsakos P and
Detmar M: TScratch: A novel and simple software tool for automated
analysis of monolayer wound healing assays. Biotechniques.
46:265–274. 2009.PubMed/NCBI
|
|
24
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Cheung ST, So S, Fan ST, Barry C,
Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al: Gene expression
patterns in human liver cancers. Mol Biol Cell. 13:1929–1939. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mas VR, Maluf DG, Archer KJ, Yanek K, Kong
X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, et al: Genes
involved in viral carcinogenesis and tumor initiation in hepatitis
C virus-induced hepatocellular carcinoma. Mol Med. 15:85–94. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roessler S, Jia H-L, Budhu A, Forgues M,
Ye Q-H, Lee J-S, Thorgeirsson SS, Sun Z, Tang Z-Y, Qin L-X, et al:
A unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wurmbach E, Chen YB, Khitrov G, Zhang W,
Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et
al: Genome-wide molecular profiles of HCV-induced dysplasia and
hepatocellular carcinoma. Hepatology. 45:938–947. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hruz T, Laule O, Szabo G, Wessendorp F,
Bleuler S, Oertle L, Widmayer P, Gruissem W and Zimmermann P:
Genevestigator V3: A reference expression database for the
meta-analysis of transcriptomes. Adv Bioinformatics.
2008:4207472008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Narita T, Yung TMC, Yamamoto J, Tsuboi Y,
Tanabe H, Tanaka K, Yamaguchi Y and Handa H: NELF interacts with
CBC and participates in 3′ end processing of replication-dependent
histone mRNAs. Mol Cell. 26:349–365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Youssef A, Shawer H, Afify A and Amleh A:
The potential involvement of the cofactor of BRCA1 in
hepatocellular carcinoma pathogenesis. Adv Mod Oncol Res. Aug
10–2016.(Epub ahead of print). doi: 10.18282/amor.v2.i4.129.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scholzen T and Gerdes J: The Ki-67
protein: From the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang X, Zheng Q and Yuan Z: Neoadjuvant
chemotherapy for hepatocellular carcinoma. Hepatocellular Carcinoma
- Future Outlook. Kaseb A: http://www.intechopen.com/books/hepatocellular-carcinoma-future-outlookJuly
22–2015.
|
|
34
|
Schlüter C, Duchrow M, Wohlenberg C,
Becker MH, Key G, Flad HD and Gerdes J: The cell
proliferation-associated antigen of antibody Ki-67: A very large,
ubiquitous nuclear protein with numerous repeated elements,
representing a new kind of cell cycle-maintaining proteins. J Cell
Biol. 123:513–522. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fukuda S and Pelus LM: Survivin, a cancer
target with an emerging role in normal adult tissues. Mol Cancer
Ther. 5:1087–1098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jaiswal PK, Goel A and Mittal RD:
Survivin: A molecular biomarker in cancer. Indian J Med Res.
141:389–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pavlidou A, Kroupis C and Dimas K:
Association of survivin splice variants with prognosis and
treatment of breast cancer. World J Clin Oncol. 5:883–894. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mull AN, Klar A and Navara CS:
Differential localization and high expression of SURVIVIN splice
variants in human embryonic stem cells but not in differentiated
cells implicate a role for SURVIVIN in pluripotency. Stem Cell Res.
12:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kannangai R, Wang J, Liu QZ, Sahin F and
Torbenson M: Survivin overexpression in hepatocellular carcinoma is
associated with p53 dysregulation. Int J Gastrointest Cancer.
35:53–60. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Takashima H, Nakajima T, Moriguchi M,
Sekoguchi S, Nishikawa T, Watanabe T, Katagishi T, Kimura H, Minami
M, Itoh Y, et al: In vivo expression patterns of survivin and its
splicing variants in chronic liver disease and hepatocellular
carcinoma. Liver Int. 25:77–84. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zou W, Yang Y, Wu Y, Sun L, Chi Y, Wu W,
Yun X, Xie J and Gu J: Negative role of trihydrophobin 1 in breast
cancer growth and migration. Cancer Sci. 101:2156–2162. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Iida M, Iizuka N, Tsunedomi R, Tsutsui M,
Yoshida S, Maeda Y, Tokuhisa Y, Sakamoto K, Yoshimura K, Tamesa T,
et al: Overexpression of the RD RNA binding protein in hepatitis C
virus-related hepatocellular carcinoma. Oncol Rep. 28:728–734.
2012.PubMed/NCBI
|
